Xap Therapeutics is a startup based in the United Kingdom.
Xap Therapeutics is a company headquartered in the United Kingdom.
Xap Therapeutics develops tailor-made cellular therapies using genome editing and synthetic biology to create programmable immune cells designed to precisely target and treat complex diseases such as cancer and autoimmunity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.